NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS - Tanaka, Ryuma; Sullivan, Michael; Canpolat, Cengiz; Johnston, Robert; Ataseven, Eda; Ates, Dilvin Celik; Duncan, Catriona; Jorgensen, Mette; Mccarthy, Anthony; Murphy, Dermot; Storck, Simone; Opocher, Enrico; et al. (WILEY, 2023)